European Banks, Health Care and Tech in Sticky Inflation
European equities still have room to rise even as inflation remains sticky, and that is exactly why investors should be paying attention to banks, health care and technology. The market is moving into a regime where growth can coexist with higher prices, but returns will increasingly favor sectors with pricing power, balance-sheet strength and structural earnings momentum rather than broad index beta.
That is the core message behind Intesa’s upbeat view on European stocks. The call matters because persistent inflation is changing the policy backdrop, with the European Central Bank likely to stay restrictive for longer even as investors continue to hunt for earnings growth. In that environment, the winners are not the most cyclical names, but the businesses that can protect margins and reprice faster than costs rise.
Financials are the clearest expression of that trade. The European banking sector tends to benefit when inflation keeps rates elevated, because stronger net interest income can offset slower volume growth and support profitability. That helps explain why the European financials ETF, EUFN, has climbed to about 42.21 from 37.60 at the end of January, with its 50-day moving average now above the 200-day moving average — a classic sign that the trend has turned constructive. The move has also been broad enough to lift the wider Europe ETF, VGK, which has risen to 90.87 from 75.78 in late November.
The macro backdrop supports the argument. U.S. inflation remains well above pre-pandemic norms, with the consumer price index forecast at 333.97 for August after 332.81 in July, while the 10-year Treasury yield sits near 4.75%, underlining how stubborn global rate pressures remain. Even if those figures are U.S.-based, they reinforce a world in which central banks cannot fully pivot to easy money, and that keeps a premium on sectors that can generate cash rather than merely promise growth.
That is where the market is missing the deeper opportunity. Banks offer leverage to a higher-for-longer rate environment, but health care and technology add a different kind of resilience: steadier demand and durable secular growth. Health care can pass through price increases more effectively than most sectors, while technology remains the long-duration beneficiary of AI spending, cloud buildout and enterprise digitization. In a Europe still trading with policy uncertainty, those two groups offer a rare mix of defense and upside.
For investors, the message is not to chase every cyclical rally. It is to position for the next phase of the European market, where inflation does not kill the bull case but changes who wins. If Intesa is right, the trade is not just Europe itself — it is the parts of Europe that can turn higher rates, persistent pricing pressure and structural capex into earnings power.
The actionable takeaway is clear: stay overweight European financials, add selective exposure to health care and technology, and use broad Europe strength as confirmation rather than the main thesis. The market is still underestimating how long this inflation-led rotation can last.
| Entity | Gains | Losses |
|---|---|---|
| European banks | ▲Higher net interest income | ▼Rate-cut hopes |
| Health care stocks | ▲Pricing power | ▼Margin pressure |
| Technology stocks | ▲AI and digitization spending | ▼Low-growth defensives |
| Broad bond proxies | ▲None | ▼Higher-for-longer rates |